NIH teacher resources feature rare diseases and evolution

November 3, 2011

Teachers now have an innovative way to help students approach challenging biology questions with two new free curriculum supplements from the National Institutes of Health: Evolution and Medicine,and Rare Diseases and Scientific Inquiry. Both supplements inform students about human health, while helping them build their problem-solving, communication, critical thinking, and teamwork skills.

Teachers can easily integrate the supplements into their classes' explorations of complex topics such as the need for yearly flu vaccines, the geographical differences in rates of lactose intolerance, pros and cons of clinical trials for kids with cancer, and reasons why certain people contract . These are the latest installments in a popular NIH series aligned with state and national education standards and designed to promote inquiry-based, interdisciplinary learning and stimulate student interest in science.

The supplements were developed by leading scientists, educators, and curriculum experts, and combine cutting-edge medical research discoveries with state-of-the-art instructional materials. Each has a self-contained teacher's guide consisting of five lessons on science and human health and including online virtual labs, videos, and simulations. Educators have requested more than 400,000 supplements in the series from NIH, the federal focal point for medical research.

Evolution and Medicine, for grades 9–12,helps students use scientific inquiry in the context of medicine to understand evolutionary principles. Students will learn how evolution is part of our knowledge of human health, biomedical processes, and disease treatment. To request Evolution and Medicine, visit science.education.nih.gov/q7 .

"Evolution's signature is written all over our genomes and is manifested throughout our bodies," says Irene Eckstrand, Ph.D., an NIH expert on evolution who helped develop the curriculum. " and Medicine explains the basic principles of evolutionary biology using new and well-researched examples drawn from current medical research."

Rare Diseases and Scientific Inquiry, for grades 6–8, helps students explore how scientists research rare diseases and treatments and learn more about the workings of the human body. To request Rare Diseases and Scientific Inquiry, visit science.education.nih.gov/r7 .

"The curriculum supplement will raise student awareness of rare diseases, including where to go for accurate information," according to Stephen Groft, Pharm.D., director, Office of Rare Diseases Research, NIH. "We believe that the information provided in Rare Diseases will help eliminate the feeling of isolation and stigmatization felt by many with rare diseases."

Explore further: Study: Youths in residential treatment have high rates of health problems

Related Stories

Study: Youths in residential treatment have high rates of health problems

October 19, 2011
The issues involving a number of youths who land in residential treatment programs such as Boys Town are familiar: They have histories of juvenile delinquency; they struggle in school; they come from unstable homes; they ...

Majority of Americans think they pay more toward social security and medicare than they do

June 29, 2011
According to a newly released Stony Brook Poll conducted in association with Left Right Research, a Long Island based Marketing Research supplier, more than 81 percent of approximately 7,000 people surveyed believe that they ...

Fighting drug-resistant 'super-bugs': UCLA expert offers protection tips

May 11, 2011
The new "super-bug" CRKP, known officially as carbapenem-resistant Klebsiella pneumoniae, is just the latest in a series of emerging drug-resistant strains of bacteria that pose a serious threat to human health. CRKP ...

Losing weight, keeping it off might require distinct skill sets

July 5, 2011
A new study indicates that the practices that help people to lose weight and the practices that help them keep it off do not overlap much.

FDA announces new limits on high-dose simvastatin (Zocor)

June 9, 2011
The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and ...

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

kevinrtrs
1 / 5 (3) Nov 05, 2011
Seems like the indoctrination is reaching for a stronger foothold in areas where it does not contribute one iota.

Evolution is not required to understand or move medicine forward.

The field of Medicine has developed and grown all by itself - no evolution nonsense required, thank you very much.

So here we have the priests and prophets of evolution hard at work trying to make themselves seem important and actually useful when they are anything but. In fact, I'd say they are interfering with the progress of real, tangible and applied science.

Please spare me the nonsense of saying that because you see some changes at the genetic level in bacteria or some other organisms cell(s) that this is concrete support for molecules-to-man evolution. It's not. All the structures and allowed variability is already in there. If you disagree, please explain why the resistant bacteria didn't change into salamanders, for instance.
barakn
5 / 5 (1) Nov 06, 2011
...because it would take a billion years and the bacteria would have to fit themselves not only into the ecological niche already occupied by the salamanders (or whatever is in their place in a billion years hence) but also prior to that fit their intermediate forms into ecological niches occupied by a variety of other creatures. In other words, an ancient instance of evolution can't be reproduced in a modern environment. Kevin, you don't know enough about evolution or even biology in general to make cogent arguments against it. Every time you post you stick another dagger into the stinking corpse of creationism.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.